ISRCTN23909398Completed未知
Effect of mesenchymal stem cells in patients with detrusor hypocontractility
Federal University of Mato Grosso do Sul0 sites9 target enrollmentStarted: March 15, 2021Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 9
Study Overview
Brief Summary
2023 Results article in https://doi.org/10.1186/s13287-023-03294-8 (added 05/04/2023)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Male and female patients with a urodynamic study showing only detrusor hypocontractility, without the presence of an obstructive factor to urinary flow
- •2. On a clean intermittent catheterization regime
- •3. Not undergoing any surgical procedure in the lower urinary tract in the last 12 months
Exclusion Criteria
- •1. End-stage renal failure (with oligo-anuria)
- •2. Recurrent urinary tract infection
- •3. Non-adherence to clinical monitoring protocols and clean intermittent auto-catheterization
- •4. Presence of any malignant neoplasm confirmed in treatment or recently treated or even any suspicion of cancer will be an important exclusion criterion due to contraindication to the use of stem cells in these patients
Investigators
Similar Trials
Active, not recruiting
Phase 1
Treatment of severe infections with mesenchymal stem cellsseptic shockEUCTR2017-004123-67-FRCentre Hospitalier Régional Universitaire de Nancy66
Completed
Phase 1
Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney DiseasePolycystic Kidney DiseaseChronic Renal FailureNCT02166489Royan Institute6
Unknown
Early Phase 1
Mesenchymal Stem Cell for Osteonecrosis of the Femoral HeadOsteochondritis of the Femoral HeadNCT00813267Jianming Tan15
Unknown
Phase 1
Effect of Mesenchymal Stem Cell Transplantation for Lupus NephritisLupus NephritisNCT00659217Organ Transplant Institute, China20
Completed
Not Applicable
Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantatiorefractoty acute GVHD after stem cell transplantationJPRN-C000000423Jichi Medical University, Department of Medicine, Division of Hematology5